Diabetic foot infections are a common and serious problem for all health systems worldwide. The aim of this study was to examine the resistance to antibiotics of microorganisms isolated from infected soft tissues of diabetic foot ulcers, using tissue cultures. We included 113 consecutive patients (70 men, 43 women) with a mean age of 66.4 ± 11.2 years and a mean diabetes duration of 14.4 ± 7.6 years presenting with diabetic foot soft tissue infections. Generally, no high antibiotic resistance was observed. Piperacillin-tazobactam exhibited the lowest resistance in Pseudomonas, as well as in the other Gram-negative pathogens. In methicillin-resistant Staphylococcus aureus isolates, there was no resistance to anti-Staphylococcus agents. Of note, clindamycin, erythromycin, and amoxycillin/clavulanic acid exhibited high resistance in Gram-positive cocci. These results suggest that antibiotic resistance in infected diabetic foot ulcers in our area is not high and they are anticipated to prove potentially useful in the initial choice of antibiotic regimen.
PapanasNManiR. Advances in infections and wound healing for the diabetic foot: the die is cast. Int J Low Extrem Wounds. 2013;12:83-86.
2.
PapanasNDemetzosCPippaNMaltezosETentolourisN. Efficacy of a new heparan sulfate mimetic dressing in the healing of foot and lower extremity ulcerations in type 2 diabetes: a case series. Int J Low Extrem Wounds. 2016;15:63-67.
3.
ArmstrongDGBoultonAJMBusSA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376:2367-2375.
4.
PapanasNManiR. How to cope with the increasing burden of the diabetic foot: “better three hours too soon than a minute too late”. Int J Low Extrem Wounds. 2014;13:171-172.
5.
PanagopoulosPDrososGMaltezosEPapanasN. Local antibiotic delivery systems in diabetic foot osteomyelitis: time for one step beyond?Int J Low Extrem Wounds. 2015;14:87-91.
6.
Aragón-SánchezJ.Seminar review: a review of the basis of surgical treatment of diabetic foot infections. Int J Low Extrem Wounds. 2011;10:33-65.
7.
DemetriouMPapanasNPanopoulouMPapatheodorouKBounovasAMaltezosE. Tissue and swab culture in diabetic foot infections: neuropathic versus neuroischemic ulcers. Int J Low Extrem Wounds. 2013;12:87-93.
8.
EleftheriadouITentolourisNArgianaVJudeEBoultonAJ. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs. 2010;70:1785-1797.
9.
EdmondsM.Double trouble: infection and ischemia in the diabetic foot. Int J Low Extrem Wounds. 2009;8:62-63.
10.
ManuCAMustafaOGBatesMet al. Transformation of the multidisciplinary diabetic foot clinic into a multidisciplinary diabetic foot day unit: results from a service evaluation. Int J Low Extrem Wounds. 2014;13:173-179.
11.
Aragón-SánchezJLázaro-MartínezJLHernández-HerreroCet al. Surgical treatment of limb- and life-threatening infections in the feet of patients with diabetes and at least one palpable pedal pulse: successes and lessons learnt. Int J Low Extrem Wounds. 2011;10:207-213.
12.
LipskyBABerendtARCorniaPBet al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132-e173.
13.
DumvilleJCLipskyBAHoeyCCrucianiMFisconMXiaJ. Topical antimicrobial agents for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 2017;6:CD011038.
14.
PapanasNLazaridesMK. Diabetic foot amputations in Greece: where do we go from here?Int J Low Extrem Wounds. 2011;10:4-5.
15.
MarkandayA.Diagnosing diabetic foot osteomyelitis: narrative review and a suggested 2-step score-based diagnostic pathway for clinicians. Open Forum Infect Dis. 2014;1:ofu060.
16.
MillerJMHolmesHTKrisherK. General principles of specimen collection and handling. In: MurrayPRBaronEJJorgensenJHPfallerMAYolkenRH eds. Manual of Clinical Microbiology. 8th ed.Washington, DC: ASM Press; 2003:55-66.
17.
O’HaraCMWeinsteinMPMillerJM. Manual and automated systems for detection and identification of microorganisms. In: MurrayPRBaronEJJorgensenJHPfallerMAYolkenRH eds. Manual of Clinical Microbiology. 8th ed.Washington, DC: ASM Press; 2003:185-207.
18.
ShankarEMMohanVPremalathaGSrinivasanRSUshaAR. Bacterial etiology of diabetic foot infections in South India. Eur J Intern Med. 2005;16:567-570.
19.
CitronDMGoldsteinEJMerriamCVLipskyBAAbramsonMA. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol. 2007;45:2819-2828.
20.
AbdulrazakABitarZIAl-ShamaliAAMobasherLA. Bacteriological study of diabetic foot infections. J Diabetes Complications. 2005;19:138-141.
21.
Bravo-MolinaALinares-PalominoJPLozano-AlonsoSAsensio-GarcíaRRos-DíeEHernández-QueroJ.Influence of wound scores and microbiology on the outcome of the diabetic foot syndrome. J Diabetes Complications. 2016;30:329-334.
22.
HatipogluMMutluogluMUzunGKarabacakETurhanVLipskyBA. The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey. Eur J Clin Microbiol Infect Dis. 2014;33:871-878.
23.
HatipogluMMutluogluMTurhanVet al. Causative pathogens and antibiotic resistance in diabetic foot infections: a prospective multi-center study. J Diabetes Complications. 2016;30:910-916.
24.
GrigoropoulouPEleftheriadouIJudeEBTentolourisN. Diabetic foot infections: an update in diagnosis and management. Curr Diab Rep. 2017;17:3.
25.
PetrakisIKyriopoulosIJGinisAAthanasakisK. Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications. Expert Rev Pharmacoecon Outcomes Res. 2017;17:165-180.
